Need professional-grade analysis? Visit stockanalysis.com
$9.53M
N/A
N/A
N/A
NewcelX Ltd. (NCEL) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $4.91, up 34.15% from the previous close.
Over the past year, NCEL has traded between a low of $1.90 and a high of $29.00. The stock has lost 66.6% over this period. It is currently 83.1% below its 52-week high.
NewcelX Ltd. has a market capitalization of $9.53M.
NewcelX Ltd., a biotechnology company, engages in developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company was founded in 2008 and is headquartered in Zurich, Switzerland.
Side-by-side comparison against top Healthcare peers.